Bill > S2737

This bill, the Improving Medical Device Innovation Act, aims to streamline the process for approving and regulating medical devices. Key provisions include allowing any individual or entity to request that the Secretary of Health and Human Services recognize established national or international standards for medical devices, with the Secretary required to respond within 60 days with a written explanation for their decision, and making these rationales publicly available. The bill also mandates periodic training for Food and Drug Administration (FDA) employees on the use of recognized standards in reviewing premarket submissions for devices and requires the FDA to update guidance on recognizing and withdrawing standards, considering international experience and the potential for regulatory harmonization. Furthermore, it seeks to exempt certain Class I and Class II devices from premarket reporting requirements if the Secretary determines they no longer need such reports to ensure safety and effectiveness, with a process for public comment before final decisions are published. The bill also enhances the composition and review process of classification panels, ensuring adequate expertise relevant to the device and its intended use, and provides opportunities for device sponsors, patients, and their representatives to recommend experts and provide input during panel reviews. Finally, it establishes voluntary pilot projects to explore alternative, less burdensome methods for medical device reporting to improve data quality and efficiency, with a review by the Government Accountability Office (GAO) to assess their effectiveness and recommend potential legislative changes.